ILDONG PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,280 KRW | +1.39% |
|
+1.73% | -15.86% |
| 2023 | Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea | MT |
| 2023 | Il Dong Pharmaceutical Introduces New R&D Unit Yunovia | MT |
| Sales 2024 * | 640B 465M 635M | Sales 2025 * | 700B 509M 695M | Capitalization | 427B 310M 424M |
|---|---|---|---|---|---|
| Net income 2024 * | 35B 25.44M 34.76M | Net income 2025 * | 54B 39.26M 53.62M | EV / Sales 2024 * | 0.67 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.61 x |
| P/E ratio 2024 * |
12.2
x | P/E ratio 2025 * |
7.82
x | Employees | 1,166 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.42% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.39% | ||
| 1 week | +1.73% | ||
| Current month | -2.98% | ||
| 1 month | -7.62% | ||
| 3 months | -3.35% | ||
| 6 months | -5.39% | ||
| Current year | -15.86% |
1 week
14 720.00
15 510.00
1 month
14 380.0016 390.00
Current year
14 380.0018 570.00
1 year
14 380.0024 450.00
3 years
12 400.0079 500.00
5 years
9 280.0079 500.00
10 years
9 280.0079 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Woong-Sub Yoon
CEO | Chief Executive Officer | 56 | 16-08-02 |
Gyu-Seong Kang
DFI | Director of Finance/CFO | 58 | - |
Jin-Shik Seo
COO | Chief Operating Officer | 54 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Woong-Sub Yoon
CEO | Chief Executive Officer | 56 | 16-08-02 |
Chang-Rok Seo
BRD | Director/Board Member | 62 | - |
Gyu-Seong Kang
DFI | Director of Finance/CFO | 58 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 4 M€ | -4.41% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 15,280 | +1.39% | 69,685 |
| 24-04-25 | 15,070 | +1.34% | 106,391 |
| 24-04-24 | 14,870 | +0.61% | 48,112 |
| 24-04-23 | 14,780 | -0.34% | 37,501 |
| 24-04-22 | 14,830 | -1.26% | 59,181 |
End-of-day quote Korea S.E., April 25, 2024
More quotes
IL DONG PHARMACEUTICAL CO., LTD. is a Korea-based company mainly engaged in the manufacture of pharmaceuticals.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.86% | 310M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- A249420 Stock
